Overgenes operates its proprietary Automated Intelligence Genetics (AIG) platform, which is already fully operational and continuously evolving. The platform integrates advanced genomic analysis, prop...
Universal Diagnostics (UDX) is a next-generation diagnostics company specializing in early cancer detection using liquid biopsy . Its clients are laboratories and large diagnostic operators in the U.S...
The Asabys Innvierte Tech Transfer FCRE fund, specialised in biotechnology and medical technologies, will invest in the creation and development of innovative companies in the field of deep-tech appli...
The company will receive a €499,000 grant aimed at accelerating the industrial scale-up of its in vitro plant cell culture platform for the sustainable and controlled production of pharmaceutical ac...
Visium has grown to a team of 100 AI experts across Europe and has delivered more than 250 AI and data solutions for global leaders in life sciences, specialty chemicals and other regulated industries...
In 2025, 48% of M&A transactions in the healthcare sector in Spain involved the direct or indirect participation of financial investors, highlighting the growing interest of capital in this space
The total planned investment for the development is around €80 million, with the asset expected to be partially operational at the beginning of 2027. This financing represents one of the most signif...
The round was co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors Alta Life...
Cuatrecasas advised Columbus Venture Partners and Mérieux Equity Partners on their participation as co-lead investors in Ona Therapeutics Series B financing. Ona Therapeutics is a pioneering biopharm...
With this capital injection, Avançsa joins Aortyx’s Series A financing round, which now exceeds €15 million following the public holding’s investment. The company had previously closed a €13....
COFIDES has granted a €1.2 million loan from the Social Impact Fund (FIS) to support the growth of Irisbond, a company specializing in the development of eye-tracking-based assistive communication t...
Aquilón’s trajectory is a clear example of the potential of technology transfer in Spain. Over more than a decade, the company has developed innovative biological solutions to improve swine digesti...